Bay Shore, NYNCT06588634Now EnrollingIRB Ready

Pulmonary Embolism Clinical Trial in Bay Shore, NY

Access cutting-edge pulmonary embolism treatment through this clinical trial at a research site in Bay Shore. Study-provided care at no cost to qualified participants.

Sponsored by Inari Medical

Quick Self-Assessment

See if you qualify for this Bay Shore location

Preparing your pre-screening questions…

Expert Care in Bay Shore

Access pulmonary embolism specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related pulmonary embolism treatment provided free

Apply for This Bay Shore Location

Check if you qualify for this pulmonary embolism clinical trial in Bay Shore, NY

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Bay Shore

    Convenient for NY residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Bay Shore site if eligible
  4. 4Begin participation

About This Pulmonary Embolism Study in Bay Shore

Randomized Controlled Trial of High-Risk Pulmonary Embolism Comparing FlowTriever System vs. Standard of Care

Sponsor: Inari Medical

Who Can Participate

Inclusion Criteria

Age at enrollment ≥18 years
Objective evidence of a proximal filling defect in at least one main or lobar pulmonary artery
High-risk class of acute PE
RV dysfunction, as defined RV/LV ratio ≥1.0
Willing and able to provide informed consent, or if unable, through a Legal Authorized Representative, with permitting research without prior consent as a third option (for Europe and UK sites only), provided compliance with IRB/EC approvals and adherence to regulatory, ethical and national standards

Exclusion Criteria

Prolonged cardiac arrest with loss of consciousness associated with neurological deficit.
Imaging evidence or other evidence that suggests, in the opinion of the Investigator, the patient is not appropriate for catheter-based intervention
Known pre-existing CTEPH, or CT signs of chronic PE that may point to pre-existing CTEPH
Recent stroke (\<14 days)
Recent cranial or spinal surgery (\<14 days)
Life-threatening active bleeding or hemorrhage into a critical area
Known intracranial tumor
End-stage medical condition with life expectancy \<3 months (irrespective of the severity of acute PE), as determined by the Investigator
Known sensitivity to radiographic contrast agents that, in the Investigator's opinion, cannot be adequately pre-treated
Inability to anticoagulate the patient, or known to have heparin-induced thrombocytopenia (HIT)
Current participation in another drug or device study that may interfere with the conduct of this trial
Ventricular arrhythmias refractory to treatment at the time of enrollment
Subject has any condition for which, in the opinion of the investigator, participation would not be in the best interest of the subject (e.g., compromise the well-being or that could prevent, limit, or confound the protocol-specified assessments), including a contraindication to use of FlowTriever System per local approved labeling
Subject is part of a vulnerable population (e.g., currently pregnant, breastfeeding or incarcerated) per local definitions
Subject was previously enrolled in this study
Subject has received prior thrombolytic (systemic or catheter-directed) therapy for any reason or thrombectomy (surgical or catheter-based) therapy for index PE, within 30 days prior to randomization

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Bay Shore?

Yes, this clinical trial (NCT06588634) has an active research site in Bay Shore, NY that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Pulmonary Embolism Treatment Options in Bay Shore, NY

If you're searching for pulmonary embolism treatment options in Bay Shore, NY, this clinical trial (NCT06588634) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Bay Shore research site is actively enrolling participants for this clinical trial. You'll receive care from experienced pulmonary embolism specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all pulmonary embolism clinical trials near you to find additional studies recruiting in your area.

More Pulmonary Embolism Trials in Bay Shore, NY

See all pulmonary embolism clinical trials recruiting in Bay Shore — not just this study.

Browse Pulmonary Embolism Trials in Bay Shore →

Browse More Trials by Condition

Pulmonary Embolism TrialsAll Conditions →

Ready to Join in Bay Shore?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Bay Shore, NY